Stay Updated
For all press requests, please reach out to [email protected].
News and Reports
Washington Post: Lower drug prices: Just the beginning
On a recent WP Intelligence Live Briefing, “Washington’s new push on drug pricing,” Patients For Affordable Drugs CEO Merith Basey explained why Medicare’s new negotiation authority is already delivering life-changing savings for seniors and why advocates see this as just the beginning of broader reform. Watch the full briefing here: https://www.youtube.com/watch?v=CXH2CVa9YsU
News and Reports
Epoch Times: Trump Asks Congress to Codify His Drug Price Policy Into Law
Details of the voluntary agreements have not been made public, so the full number and amount of price reductions are not known. “These arrangements do not automatically lower drug prices across the entire system, nor do they apply to most high-cost or widely used medications,” Merith Basey, CEO of Patients for Affordable Drugs, said in […]
News and Reports
Washington Post Health Brief: ICYMI: A WP Intelligence briefing
Guests Merith Basey, the CEO of Patients for Affordable Drugs, and Pharmaceutical Research and Manufacturers of America (PhRMA) Executive Vice President of Policy and Research Elizabeth Carpenter talked about the impacts of Medicare price negotiations, pharmacy benefit manager (PBM) reform, rising launch prices and what’s coming next on policy.
News and Reports
Barron’s: TrumpRx Is Here. Most People Won’t Benefit
The discounts came via negotiations between the Trump administration and drug manufacturers that aren’t codified into law, said Merith Basey, CEO of Patients for Affordable Drugs, an advocacy group. Basey says key questions for patients are how long will the discounts be available, will prices be subject to change, and will pharmacies honor them?
News and Reports
Fierce Pharma: UPDATE: TrumpRx, US government's cash-pay drug purchasing portal, has arrived
Meanwhile, patient advocacy group Patients for Affordable Drugs Now (P4AD) had several misgivings about TrumpRx following the portal’s launch. While the discounts on display will be especially useful for patients struggling to afford Novo and Eli Lilly’s GLP-1s, “these voluntary agreements lack clear enforcement mechanisms and still put the power to set and increase prices […]
News and Reports
News and Reports
Forbes: Medicare Negotiations For Next Round Of 15 Drugs Could Lead To Large Price Drops
According to the advocacy group, Patients for Affordable Drugs, several of the selected medicines saw substantial list price hikes last month, including Cimzia, Entyvio and Xeljanz, which increased by $899, $748 and $334, respectively. However, if data on list prices for drugs selected in the first and second rounds are any indicator, it’s expected that […]
News and Reports
India Currents: Why Do 47% of Americans Worry They Cannot Pay For Healthcare?
“The reality is that 1 in 3 Americans and people in this country cannot afford to pay for their prescription drugs,” said Merith Basey, Patients For Affordable Drugs. Americans are paying between 4 and 8 times, on average, what patients in other high-income countries are paying for the same brand-name drugs.